Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia.

Recombinant factor VIIa (rFVIIa) is registered for use in haemophilia with inhibitors and other rare bleeding disorders, but has also been used in various other clinical conditions to terminate life-threatening bleeding. Underlying conditions (e.g. coagulopathy) and dosing may affect treatment effic...

Full description

Bibliographic Details
Main Authors: Henri M H Spronk, Till Braunschweig, Rolf Rossaint, Dirk C Wüst, Rene van Oerle, Brian Lauritzen, Rene Tolba, Oliver Grottke
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4476676?pdf=render